Emerging nanotechnologies and their role in early ovarian cancer detection, diagnosis and interventions DOI Creative Commons

Mega Obukohwo Oyowvi,

Kehinde Henrietta Babawale,

Adedeji David Atere

et al.

Journal of Ovarian Research, Journal Year: 2025, Volume and Issue: 18(1)

Published: May 7, 2025

Ovarian cancer presents a significant public health challenge, often being diagnosed at advanced stages due to the limitations of current detection methods. This systematic review addresses urgent need for innovative approaches enhance early and diagnosis ovarian cancer. We systematically evaluate recent advancements in nanotechnology, focusing specifically on their novel applications potential comparison traditional diagnostic modalities. Our analysis encompasses wide range studies investigating nanoparticles, biosensors, imaging techniques, biomarker platforms, with an emphasis evaluating key performance indicators such as rates, turnaround times, accuracy distinguishing cancerous from non-cancerous tissues. findings indicate that nanotechnology-based have significantly improve capabilities Notably, nanoparticle-based techniques biosensors consistently demonstrate high sensitivity specificity identifying biomarkers, rates exceeding 90% reported early-stage cancers several instances. underscores promise emerging nanotechnologies transform landscape diagnosis, offering pathway toward earlier diagnoses, enhanced therapeutic interventions, improved patient outcomes. advocate future research dedicated translational efforts required move these technologies bench bedside, ensuring effectiveness is validated across diverse clinical populations.

Language: Английский

Emerging nanotechnologies and their role in early ovarian cancer detection, diagnosis and interventions DOI Creative Commons

Mega Obukohwo Oyowvi,

Kehinde Henrietta Babawale,

Adedeji David Atere

et al.

Journal of Ovarian Research, Journal Year: 2025, Volume and Issue: 18(1)

Published: May 7, 2025

Ovarian cancer presents a significant public health challenge, often being diagnosed at advanced stages due to the limitations of current detection methods. This systematic review addresses urgent need for innovative approaches enhance early and diagnosis ovarian cancer. We systematically evaluate recent advancements in nanotechnology, focusing specifically on their novel applications potential comparison traditional diagnostic modalities. Our analysis encompasses wide range studies investigating nanoparticles, biosensors, imaging techniques, biomarker platforms, with an emphasis evaluating key performance indicators such as rates, turnaround times, accuracy distinguishing cancerous from non-cancerous tissues. findings indicate that nanotechnology-based have significantly improve capabilities Notably, nanoparticle-based techniques biosensors consistently demonstrate high sensitivity specificity identifying biomarkers, rates exceeding 90% reported early-stage cancers several instances. underscores promise emerging nanotechnologies transform landscape diagnosis, offering pathway toward earlier diagnoses, enhanced therapeutic interventions, improved patient outcomes. advocate future research dedicated translational efforts required move these technologies bench bedside, ensuring effectiveness is validated across diverse clinical populations.

Language: Английский

Citations

0